About ConcePTION

ConcePTION is a project funded by the Innovative Medicines Initiative, a private public partnership. The project was launched in April 2019.

We believe that we have an important societal obligation to radically and rapidly reduce uncertainty about the effects of medication used during pregnancy and breastfeeding to benefit women in making informed decisions about medications used before, during and after pregnancy.


ConcePTION: ‘Building a pan-European ecosystem for generating, monitoring, and providing robust information on medication safety in pregnancy and breastfeeding’  | READ MORE >>
On 1-April 2019 the IMI project ConcePTION officially started. The project will tackle many of the research gaps related to medicine used by pregnant and breastfeeding women. | READ MORE >>


Our @IMIConcePTION project website just aired! Please have a look at the website at https://t.co/1kpbknuymn if you would like to know more. @IMI_JU @EFPIA

#Pregnant & #breastfeeding women require information about the #medicines they take & @IMI_JU funded project, @IMIConcePTION, wants to facilitate the need. Take the survey to support the development of better information for future #women: https://t.co/LIacThC0N8

The ConcePTION consortium

The project unites an unprecedented 88 organizations from 22 countries, including the European Medicines Agency, drug manufacturers, academia, public health organizations, and teratology networks to innovate new solutions to a decades-long public health issue.


The ConcePTION project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 821520. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.